The reason I'm asking that is because I have heard concerns about the changes that are being proposed to the PMPRB. Dr. Eyolfson made a great point when he said it's not price that's keeping us from getting more R and D. It may have to do with the amount of time and the number of hurdles that people have to go through before they have price certainty in Canada. If I look at some of the suggestions that I heard, Ms. Logan, the streamlined process sounds like a really great idea for cutting the amount of time it's going to take to get there.
Is there anything we can do to improve the price certainty at an earlier time for people who are trying to bring drugs to Canada, so we can keep those clinical trials and that research happening?